David Fei

1.1k citations
7 papers · 901 · 1 hit paper · h-index 5

Impact in

    • Retinal Diseases and Treatments
    • Retinal and Optic Conditions
    • Glaucoma and retinal disorders
    • Retinal Imaging and Analysis
    • Monoclonal and Polyclonal Antibodies Research
    • Retinal and Macular Surgery

Papers in

David Fei

6 papers receiving 833 citations

David Fei's Hit Papers

Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration 2005 · 434 citations
4340+7+14Years since publication100200300400

Peers

David Fei
Comparison fields: 5 of 74
  • Ophthalmology 464
  • Radiology, Nuclear Medicine and Imaging 295
  • Molecular Biology 290
  • Immunology 66
  • Oncology 79
Replace Naxin Guo with:
Naxin Guo United States
Jeff Faint United Kingdom
P Trenchev Canada
Mohamed A. Nouh Egypt
Arjun S. Takhar United Kingdom
Avinash Desai United States
Hiroaki Tanaka Japan
Hui Won Jang South Korea
Yi-Cheng Wang United States
David Fei relative to Naxin Guo United States Naxin Guo's profile →
Citations per field
00.5×5×10.3×
Naxin Guo · 1×
Citations per year

Countries citing papers authored by David Fei

Since Specialization
Citations

This map shows the geographic impact of David Fei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Fei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Fei more than expected).

Fields of papers citing papers by David Fei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Fei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Fei. The network helps show where David Fei may publish in the future.

Co-authors

The 25 scholars most cited alongside David Fei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Fei Line = papers co-authored together David Fei links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1
Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration
Hit paper breakdown →
2005434
2 1999220
3 2007155
4 202059
5 199628
6 20054
7 20051

About David Fei

David Fei is a scholar working on Radiology, Nuclear Medicine and Imaging, Ophthalmology, Immunology, Molecular Biology and Oncology, having authored 7 papers that have together received 901 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Biosimilars and Bioanalytical Methods (2 papers), Advanced Biosensing Techniques and Applications (2 papers), Retinal Diseases and Treatments (2 papers), Vascular Tumors and Angiosarcomas (1 paper), Viral Infectious Diseases and Gene Expression in Insects (1 paper), Angiogenesis and VEGF in Cancer (1 paper) and Xenotransplantation and immune response (1 paper). The work is most often cited by research in Ophthalmology (464 citations), Radiology, Nuclear Medicine and Imaging (295 citations), Molecular Biology (290 citations), Immunology (66 citations) and Oncology (79 citations). David Fei has collaborated with scholars based in United States, Switzerland and New Zealand. Frequent co-authors include Jacques Gaudreault, Jeriza Rusit, Yvonne S. Lin, Y. Gloria Meng, Nishit B. Modi, Enrique Escandón, Linda K. Rangell, Joseph C. Beyer, Anne Marie Ryan and Lisa A. Damico. Their work appears in journals such as Immunological Investigations, Investigative Ophthalmology & Visual Science, American Journal of Clinical Nutrition, Transplantation and Retina.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact